Kidney Cancer Treatment Options at  The Kidney Cancer Institute

Active Surveillance

Laparoscopic Kidney Cryoablation /
Radiofrequency Ablation

Percutaneous Kidney Cryoablation /
Radiofrequency Ablation

Laparoscopic Partial Nephrectomy

DaVinci® Robotic Laparoscopic
Partial Nephrectomy

Open Partial Nephrectomy

Laparoscopic Radical Nephrectomy

Open Radical Nephrectomy

Laparoscopic Cytoreductive
Nephrectomy

Open Cytoreductive Nephrectomy

Open Nephrectomy with
Vena Caval Reconstruction

 
Biotechnology That is Used to Cure Kidney Cancer

 

 

Open Cytoreductive Nephrectomy

Questions for Dr. Landman
 

Definition:
Open cytoreductive nephrectomy is the exact same operation as an open radical nephrectomy. However, the open cytoreductive nephrectomy is done in the setting of kidney cancer that has extended outside of the kidney and its surrounding tissues. The extent of the cancer may be limited to tissues in the area around the kidney known as the lymph nodes, or the kidney cancer may have more extensively spread to other organs such as the lung or liver.

Considering an open cytoreductive nephrectomy implied that, prior to the surgery, your doctor already knows that the cancer has spread outside the kidney to another organ and therefore removal of the kidney alone is not going to result in cure. After the cytoreductive other systemic treatment strategies will be needed to increase the chance of cure and to extend life as much as possible.

Open cytoreductive nephrectomy was not performed in the past if the patient did not have symptoms such as pain or bleeding. However, it has been proven in two separate large clinical trials that open cytoreductive nephrectomy afford patients a slight improvement in survival and will extend life for a period of time that is usually in the range of three months to a year.

Technique:
Open cytoreductive nephrectomy involves removal of the entire kidney but may also require the removal of adjacent organs such as the intestines, pancreas, spleen, or parts of the liver. The open cytoreductive nephrectomy is often a very technically challenging operation as the kidney cancer is outside the normal area of the kidney and can make control of the blood vessels that must be controlled to remove the kidney cancer quite difficult. Similarly, the cancer may have grown into nearby structures such as the liver, pancreas and spleen. As such, it is very important that the surgeon performing this procedure be specially trained in kidney cancer surgery of this type. Additionally, open cytoreductive nephrectomy should be performed at medical centers that have advanced surgeons and facilities that may be required in addition to the Urologist to optimize each patient’s outcome.

Candidates:
Candidates for open cytoreductive radical nephrectomy include relatively healthy patients with kidney cancer that has extended beyond the kidney and its immediate surrounding tissues (metastatic kidney cancer). The operation tends to benefit patients who can perform basic activities of daily living by themselves and who do not have symptoms from their kidney cancer. Before undergoing this type of surgery, patients should discuss their situation with a Urologist who specializes in advanced kidney cancer and who has extensive experience with this open cytoreductive nephrectomy.

Advantages / Disadvantages:

While open cytoreductive nephrectomy is a large operation that requires significant time for recovery, it can offer healthier patients with kidney cancer that has spread beyond the area of the kidney and its immediate surrounding tissues a chance for cure. Certainly, the open cytoreductive nephrectomy has been shown to extend the life of patients with kidney cancer that has spread to other parts of the body. The amount of time that open cytoreductive nephrectomy will extend life is variable, but will typically range from several months to a year.

Follow-up:
Follow-up from an open cytoreductive radical nephrectomy involves an extended recovery that usually requires a couple of months for the patients to achieve full activity. Additionally, after recovery from the surgery, patients require treatment in a multidisciplinary cancer center using the state of art systemic or total body therapies.

 

 
Video Showcase

Cryoablation Video

Cryoablation Patient Interview

Cryoablation Patient Testimonial

Percutaneous Renal Cryoablation

Laparoscopic Partial Nephrectomy

Laparoscopic Radical         Nephrectomy

Robotic Partial Nephrectomy

Complementary Mangement Strategies

More details on metastatic how
kidney cancer spreads

What are the challenges in treating metastatic kidney cancer?

How does metastatic kidney cancer affect my body?

How common is metastatic kidney cancer?

Which organs are most likely to be affected by metastatic kidney cancer?

What is the prognosis of people with metastatic kidney cancer?

As a patient with metastatic kidney cancer, what should I do?

Treatment for Metastatic Kidney Cancer

Why is metastatic cancer worse than localized cancer?

How is metastatic kidney cancer treated?

En Espaņol

 

Copyright 2006 Kidney Cancer Institute            

Complementary Management Strategies | Biotechnology That is Used to Cure Kidney Cancer
Kidney Cancer Questions & Answers | About Dr. Landman | Questions for Dr. Landman

Find Us On Facebook

Website Design by Dynamic Digital Advertising
Site Guide

Home   Resources   References   News   Directions   Patient Testimonials   Contact Us

About Dr. Landman